Mackay Shields LLC’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-34,871
Closed -$6.41M 722
2021
Q2
$6.41M Sell
34,871
-1,705
-5% -$293K 0.06% 284
2021
Q1
$5.59M Sell
36,576
-39,424
-52% -$6.1M 0.04% 449
2020
Q4
$11.9M Sell
76,000
-130,512
-63% -$16.8M 0.08% 274
2020
Q3
$23.6M Buy
206,512
+96,674
+88% +$10.4M 0.16% 134
2020
Q2
$12.3M Buy
109,838
+47,998
+78% +$5.1M 0.1% 239
2020
Q1
$5.55M Buy
61,840
+6,042
+11% +$593K 0.05% 371
2019
Q4
$6.04M Sell
55,798
-4,041
-7% -$432K 0.04% 426
2019
Q3
$5.86M Buy
59,839
+9,183
+18% +$1.04M 0.04% 452
2019
Q2
$6.63M Buy
50,656
+1,538
+3% +$198K 0.05% 436
2019
Q1
$6.64M Buy
49,118
+4,615
+10% +$574K 0.05% 420
2018
Q4
$4.33M Buy
+44,503
New +$5.26M 0.04% 501
2018
Q3
Sell
-48,383
Closed -$6.01M 1264
2018
Q2
$6.01M Sell
48,383
-2,874
-6% -$336K 0.04% 439
2018
Q1
$5.71M Buy
+51,257
New +$6.13M 0.04% 474

Other funds holding ALXN